Development of antisense oligonucleotides that enhance sIL7R as novel cancer immunotherapy

Project: Research project

Project Details

StatusFinished
Effective start/end date9/1/21 → 8/31/23

Funding

  • Autoimmunity Biologic Solutions, Inc ( Award #1R43CA25710801A1): $100,815.00